Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1802268

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
COc1cc(Br)cc2nc3cc(Cl)c(Cl)cc3nc12

Basic Information

ChEMBL ID CHEMBL1802268
Phase Preclinical
Structure Type MOL
InChI Key DQLYSMRTSNEMBV-UHFFFAOYSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names

Molecular Properties

358.0
MW (Da)
4.86
ALogP
3
HBA
0
HBD
35.0
PSA (Ų)
0.58
QED
0
Ro5 Violations
1
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C13H7BrCl2N2O
MW 358.02
Aromatic Rings 3
Heavy Atoms 19
NP-Likeness -0.56

Activity Summary

IC50 1 meas. best 5.61

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 5.61 5.61 2460.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 2460.0 nM 5.61 Inhibition of NF-kappaB expressed in human HEK293 cells by luciferase reporter g... 21105712

Literature References

PubMed DOI Target Context # Activities
21105712 10.1021/jm1011066 NAD(P)H dehydrogenase [quinone] 1 2
21105712 10.1021/jm1011066 Unchecked 2
21105712 10.1021/jm1011066 Ribosyldihydronicotinamide dehydrogenase [quinone] 2
21105712 10.1021/jm1011066 RAW264.7 1

Data from ChEMBL 36 via Core Engine